A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania — Ayşegül Yıldız (2014) | RDL Network
Hierarchical rank ordering by comparative efficacy and risk of all-cause discontinuations should help to guide antimanic treatment choices by clinicians, healthcare policy makers, and guideline developers.
Mikkel Højlund, Helin Yılmaz Kafalı, Begüm Kırmızı, Paolo Fusar‐Poli, Christoph U. Correll, Samuele Cortese, Michel Sabé, Jess G. Fiedorowicz, Gayatri Saraf, Josephine Zein, Michael Berk, M. Ishrat Husain, Joshua D. Rosenblat, Ruby Rubaiyat, Kim Corace, Stanley Wong, Simon Hatcher, Mark Kaluzienski, Lakshmi N. Yatham, Andrea Cipriani, Corentin J. Gosling, Robin Carhart‐Harris, Peter Tanuseputro, Daniel T. Myran, Nicholas Fabiano, David Moher, Leah M. Mayo, Stuart G. Nicholls, Tracy White, Michele De Prisco, Joaquim Raduà, Eduard Vieta, Karim S. Ladha, Jay Katz, Areti Angeliki Veroniki, Marco Solmi
Guy M. Goodwin, Mocrane Abbar, Thomas E. Schläepfer, Heinz Grunze, Rasmus Wentzer Licht, Frank Bellivier, Konstantinos Ν. Fountoulakis, Alfredo Carlo Altamura, William Pitchot, Hans Ågren, Edith Holsboer‐Trachsler, Eduard Vieta
Andrea Cipriani, Taryn Williams, Adriani Nikolakopoulou, Georgia Salanti, Anna Chaimani, Jonathan Ipser, Philip J. Cowen, John Geddes, Dan Joseph Stein
Discussion(0)
No comments yet. Be the first to comment.